Evidence-Based Medicine Guidelines
Treating dopamimetic psychosis in Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Treating Dopamimetic Psychosis in Parkinson's Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson&apos.
Treating dopamimetic psychosis in Parkinson's disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson&apos. Accessed June 7, 2026.
Treating dopamimetic psychosis in Parkinson's disease. (2026). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson&apos
Treating Dopamimetic Psychosis in Parkinson's Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2026. [cited 2026 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson&apos.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Treating dopamimetic psychosis in Parkinson's disease
ID - 452339
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452339/all/Treating_dopamimetic_psychosis_in_Parkinson&apos
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
